Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Sep 27, 2025

Author Spotlight: Advancing Gene Silencing Research in Silkworms with dsRNA Delivery Through Feeding Chitosan Nanoparticles
05:36

Author Spotlight: Advancing Gene Silencing Research in Silkworms with dsRNA Delivery Through Feeding Chitosan Nanoparticles

Published on: October 4, 2024

2.2K

Efficient delivery of Echinococcus multilocularis miRNAs using chitosan nanoparticles.

Yue Sun1, Yongjie Kou2, Xuedong He2

  • 1School of Chemistry and Chemical Engineering, School of Biological and Pharmaceutical Engineering, Lanzhou Jiaotong University, Lanzhou 730070, Gansu, China; State Key Laboratory of Veterinary Etiological Biology, Key Laboratory of Veterinary Parasitology of Gansu Province, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou 730046, Gansu, China.

Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|April 11, 2022
PubMed

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reinfection dynamics of owned dogs with Echinococcus granulosus sensu lato in endemic rural areas of central Iran: Implications for cystic echinococcosis control.

PLoS neglected tropical diseases·2026
Same author

Egrets Promote the Transmission and Spread of Plasmid-Mediated Colistin Resistance Gene <i>mcr-1</i>-Bearing <i>Escherichia coli</i> Strains in Crested Ibis.

Transboundary and emerging diseases·2026
Same author

Fasciola hepatica excretory-secretory products attenuate demyelination and reduce neuroinflammation in the Cuprizone -induced multiple sclerosis model.

PloS one·2026
Same author

(2R,6R)-HNK improved LPS-induced depression-like behavior by inhibiting Vcam1/Caspase-1/IL-1β pathway.

International immunopharmacology·2026
Same author

The US-Israeli war is driving a displacement crisis in Iran.

BMJ (Clinical research ed.)·2026
Same author

Population-based ultrasound prevalence and risk factors for cystic echinococcosis in endemic Kazakhstan.

PLoS neglected tropical diseases·2026
Summary

Chitosan nanoparticles effectively deliver microRNAs (miRNAs) to the liver, offering a promising therapeutic strategy against Echinococcus multilocularis infection. This approach protects miRNAs from degradation and targets parasitic disease control.

Area of Science:

  • Parasitology
  • Nanotechnology
  • Molecular Biology

Background:

  • Alveolar echinococcosis, caused by Echinococcus multilocularis, is a significant zoonotic threat with limited therapeutic options.
  • MicroRNAs (miRNAs) are crucial regulators in disease and potential therapeutic targets for parasitic infections.
  • Challenges in miRNA therapy include poor cellular uptake and degradation; chitosan nanoparticles offer a potential solution.

Purpose of the Study:

  • To develop and characterize miRNA-bearing chitosan nanoparticles (CS NPs) for targeted delivery.
  • To evaluate the physicochemical properties, cellular uptake, and liver tropism of CS NPs.
  • To assess the efficacy of CS NPs in delivering Echinococcus multilocularis miR-4989 (emu-miR-4989) for therapeutic intervention.

Main Methods:

Keywords:
CS nanoparticleChitosanEchinococcus multilocularisEmu-miR-4989MiRNA

More Related Videos

Chitosan/Interfering RNA Nanoparticle Mediated Gene Silencing in Disease Vector Mosquito Larvae
08:36

Chitosan/Interfering RNA Nanoparticle Mediated Gene Silencing in Disease Vector Mosquito Larvae

Published on: March 25, 2015

14.5K
Enhanced Gene Delivery and Expression using Intraosseous Injection of Chitosan Nanoparticles Encapsulated Adenine Base Editor Plasmids
07:14

Enhanced Gene Delivery and Expression using Intraosseous Injection of Chitosan Nanoparticles Encapsulated Adenine Base Editor Plasmids

Published on: May 16, 2025

201

Related Experiment Videos

Last Updated: Sep 27, 2025

Author Spotlight: Advancing Gene Silencing Research in Silkworms with dsRNA Delivery Through Feeding Chitosan Nanoparticles
05:36

Author Spotlight: Advancing Gene Silencing Research in Silkworms with dsRNA Delivery Through Feeding Chitosan Nanoparticles

Published on: October 4, 2024

2.2K
Chitosan/Interfering RNA Nanoparticle Mediated Gene Silencing in Disease Vector Mosquito Larvae
08:36

Chitosan/Interfering RNA Nanoparticle Mediated Gene Silencing in Disease Vector Mosquito Larvae

Published on: March 25, 2015

14.5K
Enhanced Gene Delivery and Expression using Intraosseous Injection of Chitosan Nanoparticles Encapsulated Adenine Base Editor Plasmids
07:14

Enhanced Gene Delivery and Expression using Intraosseous Injection of Chitosan Nanoparticles Encapsulated Adenine Base Editor Plasmids

Published on: May 16, 2025

201
  • Preparation and characterization of miRNA-bearing chitosan nanoparticles.
  • Assessment of nanoparticle stability, miRNA protection, cytotoxicity, cellular uptake, and liver tropism in vitro and in vivo.
  • In vitro and in vivo delivery of emu-miR-4989 using CS NPs.
  • Quantification of UBE2N mRNA and protein expression in response to emu-miR-4989 delivery.
  • Main Results:

    • Chitosan nanoparticles demonstrated good stability, protected miRNAs from degradation, and exhibited low cytotoxicity.
    • CS NPs showed efficient cellular absorption and significant liver tropism.
    • In vitro and in vivo delivery of emu-miR-4989 via CS NPs led to reduced UBE2N expression at both mRNA and protein levels in the liver.

    Conclusions:

    • Chitosan nanoparticles serve as an effective vehicle for liver-targeted delivery of miRNAs.
    • This CS NP-based miRNA delivery system shows potential for developing novel therapeutics against Echinococcus multilocularis infection.